Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Quantum Dots Could Supercharge Antibiotic Treatments

By Ryan Bushey | October 5, 2017

Engineers may have found a new way to boost the effectiveness of antibiotics to combat the spread of resistant superbugs.

Researchers from the University of Colorado at Boulder found that quantum dots, a series of light-activated nanoparticles, can interfere with important processes performed by bacteria making them more susceptible to the original antibiotic.

The team introduced these nano-engineered quantum dots to certain clinical isolate infections where they can be deployed selectively and activated or de-activated using specific wavelengths of light.

The dots differ from previous antibiotic treatments because they are able to work selectively on an intracellular level. They are small enough to slip inside and help clear the infection from within.

“We’ve developed a one-two knockout punch,” said co-lead study author and assistant professor in CU Boulder’s Department of Chemical and Biological Engineering (CHBE) Prashant Nagpal, in a statement. “The bacteria’s natural fight reaction [to the dots] actually leaves it more vulnerable.”

A chemical called superoxide is released by these molecules, which ends up interfering with the bacterium’s metabolic and cellular processes reducing the effective antibiotic resistance of the isolate infections by a factor of 1,000 without inducing adverse side effects.

“We are thinking more like the bug,” said another co-lead author of the study Anushree Chatterjee, an assistant professor in CHBE, in a statement. “This is a novel strategy that plays against the infection’s normal strength and catalyzes the antibiotic instead.”

Ultimately, the researchers feel the biggest advantage of this quantum dot technology is that it gives clinicians a flexible multipronged approach to fighting infections that are already straining the limits of current treatments.

Findings from this research were published in the journal Science Advances.


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE